Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Potential cancer gene therapy by baculoviral transduction.

Wang S, Balasundaram G.

Curr Gene Ther. 2010 Jun;10(3):214-25. Review.

PMID:
20402653
2.

Baculovirus-transduced bone marrow mesenchymal stem cells for systemic cancer therapy.

Bak XY, Yang J, Wang S.

Cancer Gene Ther. 2010 Oct;17(10):721-9. doi: 10.1038/cgt.2010.32. Epub 2010 Jun 11.

PMID:
20539321
3.

Adenovirus-based cancer gene therapy.

Kaplan JM.

Curr Gene Ther. 2005 Dec;5(6):595-605. Review.

PMID:
16457649
4.

Towards the use of baculovirus as a gene therapy vector.

Pieroni L, La Monica N.

Curr Opin Mol Ther. 2001 Oct;3(5):464-7. Review.

PMID:
11699890
5.

Adenoviral strategies for the gene therapy of cancer.

Relph KL, Harrington KJ, Pandha H.

Semin Oncol. 2005 Dec;32(6):573-82. Review.

PMID:
16338423
6.

Vector-mediated cancer gene therapy: an overview.

Seth P.

Cancer Biol Ther. 2005 May;4(5):512-7. Epub 2005 May 5. Review.

PMID:
15908802
7.

Gene therapy for cancer: what have we done and where are we going?

Roth JA, Cristiano RJ.

J Natl Cancer Inst. 1997 Jan 1;89(1):21-39. Review.

PMID:
8978404
8.

Baculovirus vectors: novel mammalian cell gene-delivery vehicles and their applications.

Hüser A, Hofmann C.

Am J Pharmacogenomics. 2003;3(1):53-63. Review.

PMID:
12562216
9.

Tumor targeting of baculovirus displaying a lymphatic homing peptide.

Mäkelä AR, Enbäck J, Laakkonen JP, Vihinen-Ranta M, Laakkonen P, Oker-Blom C.

J Gene Med. 2008 Sep;10(9):1019-31. doi: 10.1002/jgm.1222.

PMID:
18655234
10.

Transcriptional targeting of virus-mediated gene transfer by the human hexokinase II promoter.

Määttä AM, Korja S, Venhoranta H, Hakkarainen T, Pirinen E, Heikkinen S, Pellinen R, Mäkinen K, Wahlfors J.

Int J Mol Med. 2006 Nov;18(5):901-8.

PMID:
17016620
11.

Viral vectors for cancer immunotherapy.

Harrop R, Carroll MW.

Front Biosci. 2006 Jan 1;11:804-17. Review.

PMID:
16146772
12.

Recombinant baculovirus containing the diphtheria toxin A gene for malignant glioma therapy.

Wang CY, Li F, Yang Y, Guo HY, Wu CX, Wang S.

Cancer Res. 2006 Jun 1;66(11):5798-806.

13.

Gene expression profiling to define host response to baculoviral transduction in the brain.

Boulaire J, Zhao Y, Wang S.

J Neurochem. 2009 Jun;109(5):1203-14. doi: 10.1111/j.1471-4159.2009.06015.x. Epub 2009 Apr 17.

14.

Recombinant baculovirus as a highly potent vector for gene therapy of human colorectal carcinoma: molecular cloning, expression, and in vitro characterization.

Paul A, Jardin BA, Kulamarva A, Malhotra M, Elias CB, Prakash S.

Mol Biotechnol. 2010 Jun;45(2):129-39. doi: 10.1007/s12033-010-9248-7.

PMID:
20143184
15.

Viral vectors in cancer immunotherapy: which vector for which strategy?

Collins SA, Guinn BA, Harrison PT, Scallan MF, O'Sullivan GC, Tangney M.

Curr Gene Ther. 2008 Apr;8(2):66-78. Review.

PMID:
18393828
16.

Baculoviral vectors for gene delivery: a review.

Hu YC.

Curr Gene Ther. 2008 Feb;8(1):54-65. Review.

PMID:
18336250
17.

Cancer gene therapy by adenovirus-mediated gene transfer.

Wu Q, Moyana T, Xiang J.

Curr Gene Ther. 2001 May;1(1):101-22. Review.

PMID:
12109134
18.

INGN 201: Ad-p53, Ad5CMV-p53, adenoviral p53, p53 gene therapy--introgen, RPR/INGN 201.

[No authors listed]

Drugs R D. 2007;8(3):176-87. Review.

PMID:
17472413
19.

Viral-mediated gene transfer for cancer treatment.

Wilson DR.

Curr Pharm Biotechnol. 2002 Jun;3(2):151-64. Review.

PMID:
12022258
20.

Tumor-targeting of viral vectors for cancer gene therapy by using antibodies or their genes against tumor-associated antigens.

Kuroki M, Kuroki M, Shibaguchi H, Hachimine K, Kinugasa T, Badran A.

Anticancer Res. 2004 Sep-Oct;24(5C):3373-7.

Supplemental Content

Support Center